To further examine if integrin α10 subunit/TRIO/RICTOR axis is important in myxofibrosarcoma in vivo, the authors evaluated pharmacological inhibitors of the pathway in xenograft models. This evidence concerns the gene RICTOR and myxofibrosarcoma.